product summary
Loading...
company name :
Santa Cruz Biotechnology
product type :
antibody
product name :
Oct-1 (12F11) Antibody
catalog :
sc-8024
quantity :
200 µg/ml
price :
279 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
12F11
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, EMSA, immunohistochemistry - paraffin section
more info or order :
citations: 12
| Published Application/Species/Sample/Dilution | Reference |
|---|---|
| |
| |
| Klar M, Bode J. Enhanceosome formation over the beta interferon promoter underlies a remote-control mechanism mediated by YY1 and YY2. Mol Cell Biol. 2005;25:10159-70 pubmed
|
Mueller B, Pabst T, Fos J, Petkovic V, Fey M, Asou N, et al. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood. 2006;107:3330-8 pubmed
| |
Malin S, Linderson Y, Almqvist J, Ernberg I, Tallone T, Pettersson S. DNA-dependent conversion of Oct-1 and Oct-2 into transcriptional repressors by Groucho/TLE. Nucleic Acids Res. 2005;33:4618-25 pubmed
| |
Oren T, Torregroza I, Evans T. An Oct-1 binding site mediates activation of the gata2 promoter by BMP signaling. Nucleic Acids Res. 2005;33:4357-67 pubmed
|
product information
Product Name :
Oct-1 (12F11) Antibody
Gene Name :
POU2F1
Size :
200 µg/ml
Price :
279 USD
Catalog Number :
sc-8024
Type :
Monoclonal
Host :
mouse monoclonal
Antigen :
Oct-1
reactive species :
m, r, h, Xenopus laevis
Application :
WB, IP, IF, IHC(P)
Epitope :
462-760 ( Xenopus )
Delivery Time :
Next day delivery in US for orders placed by 3:00 PM; Two day delivery for orders shipped internationally from our US office; Next day delivery to European customers placing orders from our European office
more info or order :
company information

Santa Cruz Biotechnology
2145 Delaware Avenue
Santa Cruz, CA 95060
Santa Cruz, CA 95060
scbt@scbt.com
https://www.scbt.com1.800.457.3801
headquarters: USA
related products
browse more products
questions and comments
